Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-01-26 @ 7:17 AM
Study NCT ID:
NCT03949192
Status:
UNKNOWN
Last Update Posted:
2020-05-05
First Post:
2019-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Kangliuwan for Recurrent Grade IV Glioma
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LYS [2019] 027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None